Delivery Order SPE2DB20D2014-SPE2DB24FA83B
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of Xifaxan 550 mg tablets. The contract is a firm-fixed-price agreement with a ceiling value of $5,163.41 and a completion date of May 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xifaxan 550 mg tablets. The contract has a ceiling value of $21,803.56 and runs through August 9, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,406.52 delivery order is for the supply of Xifaxan 550 mg tablets. The contract is a firm fixed-price Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This IDC, valued at up to $999,999,999.00, serves as a...
- This is a Delivery Order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,920.34, is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The IDC held by Amerisourcebergen with the DLA Troop Support Medical is valued at $999,999,999 and runs through November 2026, providing a...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,235.47 firm-fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a prescription medication, with a period of performance ending on November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The $14,823.58 delivery order is for 60 tablets of the medication Xifaxan 550 mg. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is the prime contractor for...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $19,135.11 delivery order is for the supply of XIFAXAN 550 mg tablets, a brand name pharmaceutical product. The delivery order was awarded on a firm fixed price basis and does not include any set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,987.59, is for the delivery of XIFAXAN 550 mg tablets. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 5, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $17,556.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60-tablet bottles of Xifaxan 550 mg on September 12, 2025, with a completion date of September 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The $56,660.39 contract has a performance period ending on May 27, 2022 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...